Clinical Trials Browser

Interventional × Osteolysis × Plasma cell × Clear all

Motor Activity, Multiple Myeloma, Osteolysis

NCT02286830 2023-02-17

Magnolia

Phase 4 Completed

158 enrolled

Plasma cell

Multiple Myeloma, Osteolysis, Osteonecrosis

NCT01447914 2019-08-28

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma

Phase 2 Completed

16 enrolled 11 charts

Classical hematologyOther hematologic neoplasmPlasma cell

Amyloidosis, Anemia, Bone Diseases, Metabolic, Fractures, Spontaneous, Hypercalcemia, Multiple Myeloma, Osteolysis, Paraproteinemias, Hematologic Neoplasms, Renal Insufficiency

Clinical Trials

GMMG-HD8-INDEX

Magnolia

Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma